Compare Corticosteroid

15 products »

close Created with Sketch.

Ozurdex

Allergan

Ozurdex (dexamethasone intravitreal implant) is a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO), non-infectious uveitis affecting the posterior segment of the eye, and diabetic macular edema.

At-a-Glance
  • Mechanism of Action: Dexamethasone, a corticosteroid, has been shown to suppress inflammation by inhibiting multiple inflammatory cytokines resulting in decreased edema, fibrin deposition, capillary leakage and migration of inflammatory cells.
  • Dosage: The intravitreal implant containing dexamethasone 0.7 mg is contained in the Novadur solid polymer drug delivery system.

Details

FDA

Yes

CE Mark

Not specified

Active Ingredients

Dexamethasone

Application

Intravitreal

Status

Prescription

Strength

0.7 mg

From Your Peers

Common Posterior Segment Conditions

READ ARTICLE »

Innovations in Diabetic Eye Disease

READ ARTICLE »

Show More

Company Information

Contact the company for additional information, availability, or pricing:

Allergan

allergan.com

5 Giralda Farms

Madison, NJ 07940